The MosaiQ AiPlex CD is designed to improve the  accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows EYSINS, Switzerland , Feb.

Request To Download Free Sample of This Strategic Report@ Highlighted with 25 tables and 60 figures, this 131-page report North America In Vitro Diagnostics (IVD) Market 2021-2031 by Product ...

Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031. The global in vitro diagnostics (IVD) market encompasses a wide range of ...

Fapon has introduced its technology transfer and local manufacturing services to best underscore its commitment to enhancing ...

Revvity Inc. reported its financial results for the fourth quarter of 2024, revealing a slight beat in earnings per share (EPS) but a miss on revenue expectations. The company's actual EPS of $1.42 ...

The global in vitro diagnostics (IVD) market is projected to grow steadily at a CAGR of 4.8%, increasing from USD 81.3 ...

Barclays analyst Luke Sergott maintained a Buy rating on Revvity (RVTY – Research Report) today and set a price target of $135.00. The ...

The "IVD In Cardiology and Neurology Market by Product Type, by Technology, by End-User, and By Region" report has been added ...

Erba Transasia Group, India’s No. 1 In-vitro Diagnostic (IVD) Company and among the leading global IVD players focused on emerging markets, today introduced Erba H7100 – its advanced Haematology ...

Thermo Fisher subsidiary Microgenics, meanwhile, also gained clearance for the Alinity C Benzodiazepines Reagent Kit, a urine-based test for benzodiazepines and their metabolites. The immunoassay is ...

The document provides predetermined acceptance criteria to ensure the safety and performance of in-vitro diagnostics (IVD) devices, in line with Medical Device Rules, 2017 and CDSCO requirements.

IVD遭遇周期不改长期成长逻辑 不仅是塞力医疗，2024年IVD企业普遍出现业绩缩水。截止到1月18日，根据上市企业2024年度业绩预告显示，包括热景生物、之江生物在内的13家IVD上市企业全部亏损，累计亏损金额超过了23亿元人民币。 一方面，疫情后IVD相关产品需求 ...